Immunotherapy Today

Immunotherapy News From Around The World

< Immunotherapy Today home

Author: btwatson

  • Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer – MD Linx
  • New tool identifies which cancer patients are most likely to benefit from immunotherapy – Medical Xpress
    New tool identifies which cancer patients are most likely to benefit from immunotherapy – Medical Xpress
  • Immunotherapy with a sting – Science Magazine
  • Pursuing Immunotherapy for Sarcoma Treatment – www.oncnursingnews.com/
    Pursuing Immunotherapy for Sarcoma Treatment – www.oncnursingnews.com/
  • New tool identifies which cancer patients are most likely to benefit from immunotherapy – Science Daily
  • New tool identifies which cancer patients are most likely to benefit from immunotherapy – EurekAlert
    New tool identifies which cancer patients are most likely to benefit from immunotherapy – EurekAlert
  • Study Finds Young, Female Patients Do Not Respond as Well to Immunotherapy – Cancer Network
    Study Finds Young, Female Patients Do Not Respond as Well to Immunotherapy – Cancer Network
  • New tool identifies which cancer patients are most likely to benefit from immunotherapy – Medical Xpress
    New tool identifies which cancer patients are most likely to benefit from immunotherapy – Medical Xpress
  • Immunotherapy Should Not Be Withheld Because of Sex, Age, or PS – Medscape
    Immunotherapy Should Not Be Withheld Because of Sex, Age, or PS – Medscape
  • Cancer Immunotherapy Market To Reach US$ 200 Billion By 2026 | – Medgadget
    Cancer Immunotherapy Market To Reach US$ 200 Billion By 2026 | – Medgadget
< Newer Entries   |   Older Entries >
Copyright 2018 ImmunoTherapyToday.com